Virtual reality treatment for quitting smoking
Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation
NA · University Hospital, Clermont-Ferrand · NCT04610931
This study tests a virtual reality program that helps people who smoke at least 10 cigarettes a day learn to quit by facing situations that make them want to smoke.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | University Hospital, Clermont-Ferrand (other) |
| Locations | 1 site (Clermont-Ferrand, Auvergne) |
| Trial ID | NCT04610931 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a virtual reality program designed to help individuals quit smoking by simulating high-risk relapse situations. It combines virtual reality exposure therapy with cognitive behavioral therapy to modify patients' cravings and emotional responses related to tobacco use. Participants will engage in immersive experiences that aim to reinforce coping strategies and reduce the desire to smoke. The study focuses on individuals who smoke at least 10 cigarettes per day and are motivated to quit.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 75 who smoke at least 10 cigarettes daily and wish to quit.
Not a fit: Patients with severe psychiatric disorders, unstable medical conditions, or cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve smoking cessation rates and reduce relapse among smokers.
How similar studies have performed: Other studies have shown promise in using virtual reality for addiction treatment, suggesting potential success for this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female between 18 and 75 years of age * Who smokes 10 or more cigarettes per day in the month prior to inclusion * Who wants to quit smoking * Who has a diagnosis of a smoking disorder with "craving" criteria according to DSM 5 criteria * Who is able to speak and read French * Who is covered by the French national health insurance system * Who has a signed consent form Exclusion Criteria: * Subjects with decompensated psychiatric co-morbidities (DSM 5) or unstable organic disease * Subjects at serious suicide risk * Subjects with other substance use disorders (DSM 5) * Problems that interact with 3D exposure: tendency to dissociation; interceptive phobias (panic attacks and hypochondria...); severe dizziness. * Cognitive problems that limit or prevent the ability to implement coping strategies or the management of emotions or stimuli and disabilities to complete the questionnaires * Subjects belonging to a protected population such as pregnant women, breastfeeding women, guardians * Subjects deprived of liberty by judicial or administrative decision, subject to psychiatric treatment under duress, minor subject, or unable to express their consent * Who refuses to participate
Where this trial is running
Clermont-Ferrand, Auvergne
- Clermont-Ferrand University Hospital — Clermont-Ferrand, Auvergne, France (RECRUITING)
Study contacts
- Study coordinator: Lise LACLAUTRE
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: 0473754963
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Tobacco Use Cessation, Addiction, Tobacco, Virtual Reality Exposure Therapy, Cognitive Behaviour Therapy